# Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel

> **NCT01666418** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 19 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Pazopanib/Paclitaxel

## Key facts

- **NCT ID:** NCT01666418
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-10
- **Final completion:** 2015-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666418, "Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01666418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*